Form 4: NeuroPace Chief Medical Officer Reports Routine Stock Disposition for Tax Purposes

NeuroPace Inc.'s Chief Medical Officer, Martha Morrell, reported the disposition of 357 shares of common stock at $12.66 per share to cover tax withholding obligations.

Summary

• Martha Morrell, Chief Medical Officer of NeuroPace Inc. (NPCE), filed a Form 4 reporting a change in beneficial ownership.
• The transaction occurred on May 27, 2025, and involved the disposition of 357 shares of NeuroPace Common Stock.
• The shares were disposed of at a price of $12.66 per share.
• The transaction code 'F' indicates a disposition to satisfy tax withholding obligations upon the vesting of equity awards.
• Following this transaction, Martha Morrell beneficially owns 87,281 shares of NeuroPace Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary insider transaction for tax purposes, which does not reflect a change in the company's operational or financial performance.

Positives

• The transaction is a routine disposition of shares (Code F) for tax withholding, which is a common and expected event for executives receiving equity compensation, indicating normal compensation practices.

Negatives

• The disposition of shares, while routine for tax purposes, represents a reduction in the insider's direct holdings, though it is not indicative of a negative outlook on the company's future.

Risks

• No new specific risks are identified directly from this routine insider transaction. The disposition is for tax purposes and does not signal a change in the company's operational or financial risk profile.

Future Outlook

N/A This Form 4 filing reports a past insider transaction and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

N/A This Form 4 filing details a specific insider transaction and does not offer broader industry context or trends.

Related Party Transactions

• The reported transaction is a disposition of common stock by Martha Morrell, the Chief Medical Officer, which is a routine insider transaction involving a related party (company officer).

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine, small-scale insider transaction for tax purposes, not indicative of a change in company fundamentals or strategy.

Next Steps

• N/A This Form 4 filing reports a completed insider transaction and does not specify future actions or milestones for the company.

Key Dates

Recommendation

Keywords

NeuroPace, NPCE, Form 4, insider transaction, stock disposition, Martha Morrell, Chief Medical Officer, common stock, tax withholding